AFFIRM-AHF: Key Takeaways

AFFIRM-AHF: Key Takeaways

ReachMD Healthcare Image
RestartResume

Find out what the latest data from the AFFIRM-AHF trial tell us about treatment with intravenous iron in patients with acute heart failure.

  • Overview

    Hospitalizations due to acute heart failure represent a growing healthcare problem and a large economic burden. Iron deficiency, irrespective of anemia, is prevalent among this population and is associated with a high risk for increased mortality and rehospitalization. Tune in to discover the latest data from the AFFIRM-AHF trial. What does this new information reveal about treatment with intravenous iron in patients with acute heart failure?

Facebook Comments

Register

We’re glad to see you’re enjoying Medtelligence…
but how about a more personalized experience?

Register for free